EPA Moves to Ease Pollution Limits on Medical Sterilization Chemical, Rekindling Health Debate

BY Rosemary

The Environmental Protection Agency on Friday unveiled a proposal to relax air-pollution standards governing emissions of ethylene oxide, a chemical widely used to sterilize critical medical equipment. The move would roll back stricter limits adopted during the previous administration after regulators warned of elevated cancer risks associated with long-term exposure near sterilization facilities.

Agency officials said the proposed changes are aimed at preventing disruptions to the domestic supply of essential health-care products, arguing that existing rules could hamper manufacturers’ ability to ensure the steady availability of sterile devices such as catheters, pacemakers and syringes. The chemical, often referred to as EtO, is used to sterilize roughly half of all medical equipment in the United States because of its effectiveness in eliminating bacteria and other pathogens on heat-sensitive materials.

EPA Administrator Lee Zeldin said the draft regulation reflects a broader effort to balance public health protection with supply-chain stability. He emphasized that maintaining access to life-saving medical technology remains a priority while the agency seeks to minimize potential risks to workers and communities located near sterilization plants.

The proposal marks one of several recent regulatory actions undertaken under President Donald Trump that aim to ease environmental compliance burdens for industry. Earlier this year, federal officials moved to weaken limits on mercury emissions from coal-fired power plants and rescinded a key scientific determination that had served as the foundation for nationwide efforts to curb greenhouse gas pollution.

The current debate over ethylene oxide standards stems from a rule finalized in 2024 that sought to cut emissions from nearly 90 commercial sterilization facilities by as much as 90 percent. That earlier regulation also required companies to conduct regular air monitoring and verify that pollution-control systems were functioning effectively. Supporters of the stricter standards argued that they were necessary to address mounting evidence linking prolonged exposure to increased risks of leukemia, breast cancer and other serious illnesses.

Public health organizations, including the American Lung Association, welcomed the 2024 rule as a critical step toward reducing cancer risks for residents living in the vicinity of sterilization plants. Environmental advocates have also raised concerns that many of the facilities are located in densely populated urban areas or in neighborhoods with significant minority populations, amplifying longstanding environmental justice concerns.

Ethylene oxide’s dual role as both an essential sterilizing agent and a known carcinogen has complicated regulatory efforts for years. While brief or incidental exposure is generally not considered hazardous, scientific research indicates that sustained inhalation of the gas over extended periods can significantly increase the likelihood of developing certain cancers. Federal regulators first classified the compound as a human carcinogen in 2016, prompting closer scrutiny of industrial emissions and workplace safety practices.

Communities across the country have grappled with the consequences of the chemical’s use. In Laredo, residents and local activists mounted a sustained campaign to address emissions from a medical sterilization facility after federal assessments identified heightened cancer risks for nearby populations. Similar concerns surfaced in suburban areas outside Chicago, where monitoring detected spikes in airborne ethylene oxide levels around a plant operated by Sterigenics. The company ultimately closed the facility and reached legal settlements following a series of lawsuits.

Industry representatives have stressed that ethylene oxide remains indispensable for ensuring the safety of complex medical devices that cannot be sterilized through alternative methods such as steam or radiation. Trade groups argue that overly stringent emissions limits could discourage investment in sterilization infrastructure or force facilities to scale back operations, potentially leading to shortages of essential products used in hospitals and clinics nationwide.

Scott Whitaker, head of the Advanced Medical Technology Association, said the sector supports efforts to maintain a reliable supply of sterile equipment while also safeguarding the health of workers and surrounding communities. He noted that manufacturers are prepared to cooperate with regulators to identify practical approaches that uphold safety standards without disrupting patient care.

Critics of the proposed rollback, however, contend that weakening pollution controls could expose vulnerable populations to avoidable health risks. They argue that advances in emissions-reduction technology and stronger oversight have already demonstrated that sterilization facilities can operate while significantly limiting harmful releases into the air.

The EPA has opened a public comment period on the proposal, setting the stage for a potentially contentious regulatory process. As policymakers weigh competing priorities — protecting public health, sustaining industrial capacity and ensuring the uninterrupted availability of critical medical supplies — the outcome of the rulemaking could shape environmental and health policy debates for years to come.